arginine-glycine-aspartate-o-methyltyrosine amide and Glioma

arginine-glycine-aspartate-o-methyltyrosine amide has been researched along with Glioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De León-Rodríguez, LM; Ferro-Flores, G; García-Becerra, R; Jiménez-Mancilla, NP; Luna-Guitiérrez, MA; Ocampo-García, BE; Ordaz-Rosado, D; Romero-Piña, ME; Santos-Cuevas, CL	1

Other Studies

1 other study(ies) available for arginine-glycine-aspartate-o-methyltyrosine amide and Glioma

Article	Year
Design and biological evaluation of ⁹⁹mTc-N₂S₂-Tat(49-57)-c(RGDyK): a hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins. Nuclear medicine and biology, 2013, Volume: 40, Issue:4 Topics: Animals; Biological Transport; Cell Line, Tumor; Drug Design; Gene Expression Regulation, Neoplastic; Glioma; Humans; Integrin alphaVbeta3; Male; Mice; Multimodal Imaging; Oligopeptides; Organotechnetium Compounds; Peptide Fragments; Radionuclide Imaging; Radiopharmaceuticals; tat Gene Products, Human Immunodeficiency Virus	2013

Article

Year

Design and biological evaluation of ⁹⁹mTc-N₂S₂-Tat(49-57)-c(RGDyK): a hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins.

Nuclear medicine and biology, 2013, Volume: 40, Issue:4

Topics: Animals; Biological Transport; Cell Line, Tumor; Drug Design; Gene Expression Regulation, Neoplastic; Glioma; Humans; Integrin alphaVbeta3; Male; Mice; Multimodal Imaging; Oligopeptides; Organotechnetium Compounds; Peptide Fragments; Radionuclide Imaging; Radiopharmaceuticals; tat Gene Products, Human Immunodeficiency Virus

2013